Drugs / DCB-DM101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03033433 | Oct 2016 → Dec 2017 | type 2 diabetes mellitus | VitNovo, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCB-DM101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03033433 ↗ |
| Route | Oral | “orally” NCT03033433 ↗ |